Free Trial

STAAR Surgical (STAA) Competitors

STAAR Surgical logo
$18.16 -1.09 (-5.64%)
As of 02:31 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

STAA vs. ICUI, HAE, XRAY, QDEL, NEOG, CERS, OSUR, UTMD, ANIK, and COO

Should you be buying STAAR Surgical stock or one of its competitors? The main competitors of STAAR Surgical include ICU Medical (ICUI), Haemonetics (HAE), DENTSPLY SIRONA (XRAY), QuidelOrtho (QDEL), Neogen (NEOG), Cerus (CERS), OraSure Technologies (OSUR), Utah Medical Products (UTMD), Anika Therapeutics (ANIK), and Cooper Companies (COO). These companies are all part of the "health care supplies" industry.

STAAR Surgical vs.

ICU Medical (NASDAQ:ICUI) and STAAR Surgical (NASDAQ:STAA) are both medical companies, but which is the superior business? We will contrast the two companies based on the strength of their analyst recommendations, risk, profitability, earnings, community ranking, institutional ownership, valuation, media sentiment and dividends.

ICU Medical has a beta of 0.87, indicating that its stock price is 13% less volatile than the S&P 500. Comparatively, STAAR Surgical has a beta of 0.65, indicating that its stock price is 35% less volatile than the S&P 500.

ICU Medical received 111 more outperform votes than STAAR Surgical when rated by MarketBeat users. Likewise, 64.21% of users gave ICU Medical an outperform vote while only 53.92% of users gave STAAR Surgical an outperform vote.

CompanyUnderperformOutperform
ICU MedicalOutperform Votes
400
64.21%
Underperform Votes
223
35.79%
STAAR SurgicalOutperform Votes
289
53.92%
Underperform Votes
247
46.08%

ICU Medical has a net margin of -4.74% compared to STAAR Surgical's net margin of -6.44%. ICU Medical's return on equity of 5.05% beat STAAR Surgical's return on equity.

Company Net Margins Return on Equity Return on Assets
ICU Medical-4.74% 5.05% 2.42%
STAAR Surgical -6.44%-3.35%-2.67%

ICU Medical presently has a consensus target price of $192.67, suggesting a potential upside of 45.11%. STAAR Surgical has a consensus target price of $24.63, suggesting a potential upside of 30.64%. Given ICU Medical's stronger consensus rating and higher possible upside, research analysts clearly believe ICU Medical is more favorable than STAAR Surgical.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
ICU Medical
0 Sell rating(s)
1 Hold rating(s)
2 Buy rating(s)
1 Strong Buy rating(s)
3.00
STAAR Surgical
1 Sell rating(s)
9 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
2.00

In the previous week, ICU Medical had 7 more articles in the media than STAAR Surgical. MarketBeat recorded 20 mentions for ICU Medical and 13 mentions for STAAR Surgical. STAAR Surgical's average media sentiment score of 1.32 beat ICU Medical's score of 0.39 indicating that STAAR Surgical is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
ICU Medical
11 Very Positive mention(s)
1 Positive mention(s)
3 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral
STAAR Surgical
9 Very Positive mention(s)
2 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

STAAR Surgical has lower revenue, but higher earnings than ICU Medical. ICU Medical is trading at a lower price-to-earnings ratio than STAAR Surgical, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
ICU Medical$2.42B1.35-$29.66M-$3.83-34.67
STAAR Surgical$279.13M3.34-$20.21M-$1.44-13.09

96.1% of ICU Medical shares are owned by institutional investors. Comparatively, 96.7% of STAAR Surgical shares are owned by institutional investors. 1.5% of ICU Medical shares are owned by insiders. Comparatively, 1.0% of STAAR Surgical shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.

Summary

ICU Medical beats STAAR Surgical on 14 of the 19 factors compared between the two stocks.

Get STAAR Surgical News Delivered to You Automatically

Sign up to receive the latest news and ratings for STAA and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

STAA vs. The Competition

MetricSTAAR SurgicalOphthalmic goods IndustryMedical SectorNASDAQ Exchange
Market Cap$934.06M$10.69B$5.41B$8.53B
Dividend YieldN/A0.96%5.22%4.11%
P/E Ratio-46.0034.5626.7719.96
Price / Sales3.343.13395.44121.37
Price / Cash23.0214.5338.2534.62
Price / Book2.382.636.874.60
Net Income-$20.21M$224.27M$3.23B$248.27M
7 Day Performance8.15%5.16%5.32%2.28%
1 Month Performance14.04%21.97%13.56%16.43%
1 Year Performance-55.66%-17.33%17.86%8.15%

STAAR Surgical Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
STAA
STAAR Surgical
4.1223 of 5 stars
$18.16
-5.6%
$24.63
+35.6%
-55.0%$899.00M$279.13M-44.27960Positive News
Analyst Forecast
Buyback Announcement
ICUI
ICU Medical
4.7769 of 5 stars
$144.34
+4.4%
$192.67
+33.5%
+30.7%$3.55B$2.38B-31.5814,500Analyst Upgrade
Insider Trade
HAE
Haemonetics
4.3783 of 5 stars
$70.23
+3.0%
$97.89
+39.4%
-27.7%$3.53B$1.36B27.652,820Analyst Forecast
Gap Up
XRAY
DENTSPLY SIRONA
4.9554 of 5 stars
$16.75
+5.9%
$20.36
+21.6%
-40.6%$3.34B$3.72B-8.0915,000Gap Up
QDEL
QuidelOrtho
4.5524 of 5 stars
$37.42
+3.0%
$44.33
+18.5%
-23.6%$2.52B$2.78B-1.247,000Positive News
NEOG
Neogen
3.4314 of 5 stars
$6.50
+8.9%
$9.00
+38.5%
-54.6%$1.41B$906.00M-2.972,110High Trading Volume
CERS
Cerus
2.946 of 5 stars
$1.35
+4.7%
$3.50
+159.3%
-31.3%$258.07M$185.14M-12.27290Gap Down
OSUR
OraSure Technologies
4.0587 of 5 stars
$2.67
+6.4%
$5.50
+106.0%
-43.2%$206.89M$185.83M17.80840News Coverage
Analyst Forecast
UTMD
Utah Medical Products
2.2125 of 5 stars
$54.02
+0.8%
N/A-21.3%$177.29M$39.27M13.68180Positive News
Dividend Announcement
ANIK
Anika Therapeutics
4.1818 of 5 stars
$11.85
+1.8%
$21.33
+80.0%
-53.4%$169.94M$119.91M-1.78300
COO
Cooper Companies
3.1747 of 5 stars
$84.44
+2.6%
$110.25
+30.6%
-16.2%$16.89B$3.93B43.3014,000Positive News

Related Companies and Tools


This page (NASDAQ:STAA) was last updated on 5/21/2025 by MarketBeat.com Staff
From Our Partners